je.st
news
Texas Medicaid holds off on proposed limits for Gilead hepatitis drug
2014-04-11 23:59:42| Biotech - Topix.net
Texas is reconsidering whether to impose strict limits on Gilead Sciences' $84,000 hepatitis C treatment for patients on the state's Medicaid health plan for the poor, at the urging of outside advisers, a state official said on Friday.
Tags: texas
drug
proposed
limits
Category:Biotechnology and Pharmaceuticals